Hematology Consult

• Page or Teams message the Hematology Consult Fellow on AMION to coordinate time and location

  • Amion.com: la gen > IM-Heme/Onc > Consult Fellow A or B

• Before the first day on service, sign-out should occur from the outgoing member to the appropriate oncoming team member

• Daily Schedule: 7:30am – 5:30pm

• There are 2 Hematology consult teams. Each team includes: 1-2 Residents, 1 fellow, 1 attending

  • Hematology Consult A: Non-Malignant

  • Hematology Consult B: Malignant

• Daily schedule is dependent on attending and clinic schedule, but rounds will generally take place at 10am

• Consults may be called in by the Emergency Department, OB/Gyn triage, or any primary inpatient service, including, but not limited to general inpatient medicine, MICU, ACS, SICU.

• Consults will be sent to the Fellow who will then distribute consults to the team on Teams

• Consults will be noted as being Emergent, Urgent, or Routine

  • Emergent consults must be reviewed and co-signed by fellow and/or faculty within two hours. Review by faculty must occur within 24 hours or sooner if appropriate.

  • Urgent consults must be reviewed and co-signed by fellow and/or faculty within 8 hours. Review by faculty must occur within 24 hours.

  • Routine consults must be seen, reviewed, and co-signed by fellow and/or faculty within 24 hours. Fellows may review and co-sign consultations prior to review by faculty.

• Residents will attending both Hematology Clinics, regardless of their assigned team:

  • Malignant Hematology Clinic: Tuesdays 1pm-5pm (Clinic Tower A2C)

  • Jail Hematology Clinic: Wednesday morning, variable times of patients (Jail RN will reach out to the team)

  • Non-Malignant Hematology Clinic: Thursdays 1pm-5pm (Clinic Tower A2C)

• For malignant hematology consults, ensure there is a thorough hematologic history including past imaging, chemotherapy or other hematologic treatments, and relevant labs.

• For non-malignant hematology consults, there often a focus on laboratory data and trends. Please review and be prepared to present pertinent laboratory data and analysis during rounds.

• Hematologic conditions generally require a high degree of reasoning and diagnostics to determine the appropriate diagnosis. Notes should reflect this reasoning and understanding and literature should be referenced when appropriate.

• Consults should be followed until the problem is resolved and appropriate follow-up notes by the consult team should be made in the chart. When the consulting group discontinues follow-up, this should be indicated by a note in the chart.

Team members are expected to communicate all recommendations to the primary teams after rounds, by end of day via Voip or Teams.